John C. Morris

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +11

Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

Kevin C. Conlon, Enrico Lugli, Hugh C. Welles et al. · Journal of Clinical Oncology · 2014 · 702 citations · Full text

Life Sciences, Immunology, Oncology +17

Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model

Ping Yu, Jason C. Steel, Meili Zhang et al. · Clinical Cancer Research · 2010 · 210 citations · Full text

Life Sciences, Immunology, Oncology +17

TGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis

Yanli Pang, Sudheer Kumar Gara, Bhagelu R. Achyut et al. · Cancer Discovery · 2013 · 157 citations · Full text

Medicine, Cancer Biology, Oncology +17

A Pilot Study of CTLA-4 Blockade after Cancer Vaccine Failure in Patients with Advanced Malignancy

Deirdre O’Mahony, John C. Morris, Cate Quinn et al. · Clinical Cancer Research · 2007 · 153 citations

Medicine, Oncology, Pharmacology +17